Measuring parents' acceptance of non-national immunization program vaccines for children and its influencing factors during the COVID-19 pandemic in Shanghai, China.

This study aimed to understand the willingness of and affecting factors of non-national immunization program (non-NIP) vaccines among children's parents during the COVID-19 era in Shanghai, China. A cross-sectional survey was conducted with parents who attended vaccination clinics in four out of 16 districts in Shanghai, China. Data was obtained using a self-administered structured questionnaire. A multivariate logistic regression model was used to analyze factors associated with vaccination acceptability. In total, 1691 valid questionnaires were obtained. Of the participants, 69.5% (1,176/1,691) reported being interested in non-NIP vaccines for their children. Further, respondents were more likely to be willing to get non-NIP vaccines for their children if they had an income of 10,000-20,000CNY or more, an educational level of college or above, and if getting the vaccination was moderately convenient or convenient. Respondents were less likely to be willing to get the vaccines if they were in the 30-39 age group and had moderate or low satisfaction with the vaccine. Many parents are willing to get non-NIP vaccines for their children. However, some demographic factors, perceived convenience and satisfaction of vaccination, perceived necessity, safety and price barrier of non- NIP influenced the acceptability of non-NIP vaccines in Shanghai. Our findings can help guide future efforts to increase non-NIP vaccines acceptability.

Introduction

Vaccines are one of the greatest advancements in the history of public health.[1] Since the launch of the National Immunization Program (NIP), significant achievements have been made and the incidence of infectious diseases has sharply declined.[2] In China, vaccination programs are divided into NIP and non-NIP. NIP vaccines are free and mandatory and the budget for NIP vaccines is covered by the Chinese central government, while non-NIP vaccines are optional and self-paid.[3] As a result, the coverage of NIP vaccines is high.[4,5]

As an effective supplement to the NIP vaccines, the non-NIP vaccines have played an important role in disease outbreak control and prevention, helping curtail infection spread and build herd immunity. Due to limited health financing, the types of vaccines included in NIP are relatively limited. Some non-NIP vaccines that are typically included in many countries have not been included in China. For example, according to the position paper of the World Health Organization position paper, the streptococcus pneumoniae vaccine is the first choice among the high-priority vaccines, and the Haemophilus influenzae type B vaccine is also the first recommended vaccine for young children.[6] However, both of these are considered optional and constitute caregivers’ out-of -pocket expenses in China.

In recent years, the coverage rate of NIP vaccines among children has been higher[7] than the coverage rate of non-NIP vaccines.[8] Some investigations show regional differences in the coverage rate of non-NIP vaccines, which is the highest in eastern China, followed by the central region, and the lowest in Western China.[7,8] Moreover, a longitudinal follow-up study showed a remarkable decline in the willingness to receive vaccination in China since the outbreak of coronavirus disease 2019 (COVID-19).[9] Shanghai is the largest and most developed city in China with approximately 24 million people. There are more than 390 vaccination clinics that can provide non-NIP vaccines. Although the amount of non-NIP vaccines increased yearly from 2010 to 2018, few studies have investigated the acceptance of non-NIP vaccines in Shanghai since the outbreak of COVID-19.

Parents are the decision-makers for their children’s vaccination, particularly regarding administering non-NIP vaccines. This study aimed to examine the acceptability of non-NIP vaccines and the influencing factors for choosing non-NIP vaccines among parents of children in Shanghai city, so as to provide references for improving the immunization rate of non-NIP vaccines.

Methods

Study setting and subjects

This study was conducted in four of the 16 districts in Shanghai city, including Pudong, Qingpu, Xuhui, and Huangpu districts. According to the Shanghai Bureau of Statistics data, the 16 districts were stratified into two groups by their economic development, for this study, two districts were randomly selected from each group. In each district, three health service centers were selected. Most non-NIP vaccines are administered to children under the age of 6 years under the guardianship of their parents, who decide their children’s vaccines. Hence, parents with children aged 0–6 years, were recruited for this study from March 2021 to July 2021.

The sample size of this cross-sectional study[10] was calculated using the formula:

. The parameters for the calculation were set as follows: a two-tailed ɑ of 5%, the proportion of acceptance of non-NIP among parents was 50%, and a permission odds ratio (OR) or (d) of .05. The minimum sample size for each district was 385, and the total sample size was at least 1,540 for the entire city. As shown Figure 1, a total of 1700 subjects were enrolled and 1,693 interviewees volunteered to answer the self-administered questionnaire. The response rate was 99.6%. Of these volunteers, 2 were excluded because of incomplete completion of the questionnaires. Finally, 1,691 questionnaires with valid date were included in this study.

Figure 1.

Flowchart of sample size determination method.

Data collection and quality management

The study was approved by the Ethics Committee of the Shanghai Center for Disease Control and Prevention. All subjects provided informed consent before the survey. A cross-sectional survey was conducted using a self-administered questionnaire. The questionnaire was developed based on previous studies[11,12] of the Shanghai Center for Disease Control and Prevention. The internal consistency reliability of the questionnaire calculated using Cronbach’s ɑ was 0.71. The questionnaire’s contents were as follows:

Socio-demographic characteristics, such as age, sex, education, family income

Knowledge, perceived safety, efficacy, and the necessity for non-NIP vaccines. (Six items determined the knowledge of non-NIP vaccines, ranging from 0 to 1, and three items determined the perceiving safety, efficacy, and necessity, on a 5-point response scale ranging from “not at all” to “very”)

Two items determined the convenience and satisfaction of vaccination

Acceptance of and attitude toward non-NIP vaccines. Parents who wanted to get non-NIP vaccines for their children were considered as willing to accept.

Trained fieldworker conducted face-to-face interviews with the parents of children aged 0–6 years A total of 1700 subjects were randomly selected.

Statistical analysis

SPSS 17.0 (SPSS Inc, Chicago, IL) was used for the data analysis. Descriptive statistics were generated for all variables. The chi-squared test was used for univariate analysis. Multivariate logistic regression was then performed between the different acceptability groups to identify the influencing factors. Significance was assessed at an alpha = .05 level and 95% confidence interval (CI).

Results

Sociodemographic characteristics

A total of 1,691 valid questionnaires, of the 1,700 total responses from parents, were analyzed, with a valid questionnaire return ratio of 99.5%. The age distribution of participants was as follows: 35.5% of ages lay in 20–29 years, 57.6% in 30–39 years, and 6.9% were 40 years and above. Among the present sample, 50.8% (859/1,691) were residents in Shanghai, and 49.2% (832/1,691) were migrants. Further, 11.3% (191/1,691), 37.4% (168/1,691), and 51.3% (262/1,691) of the participants had studied till junior high school or below, high school or technical secondary school, college or above, respectively. Additionally, 61.0% (1,032/1,691) participants had only one child and 39.0% (659/1,691) had more than one child. A total of 6.6% (121/1,691), 41.4% (700/1,691), 22.0% (372/1,691) and 30.0% (507/1,691) of the surveyed households had a monthly income per capita of less than 2,000 CNY, 2,000–5,000 CNY, 5,000–10,000 CNY, 10,000–20,000 CNY, and more than 20,000 CNY, respectively (Table 1).

Table 1.

The socio-demographics of the participants (N = 1,691).

Variables	n	%
Gender
Male	844	49.9
Female	847	50.1
Age (years)
20–29	600	35.5
30–30	974	57.6
≥40	117	6.9
Educational level
Junior high school or less	191	11.3
High school or technical school	633	37.4
College or above	867	51.3
Immigration status
Resident	859	50.8
Migrant	832	49.2
Monthly household income per capita (CNY)
<5,000	112	6.6
5,000–10,000	700	41.4
10,000–20,000	372	22.0
>20,000	507	30.0
Number of children at home
1	664	59.8
≥2	446	40.2

Acceptability of childhood non-NIP vaccines

The results revealed that 69.5% (1,176/1,691) of participants would opt for non-NIP vaccines for their children, and the acceptability would increase to 86.3% if non-NIP vaccines were covered by health insurance. The chi-squared test results revealed that the proportion of acceptability varied by gender (χ2 = 10.70, p < .001), age group (χ2 = 189.74, p < .001), educational level (χ2 = 24.05, p < .001), immigration status (χ2 = 16.66, p < .001), and household income (χ2 = 19.75, p < .001). Most participants [76.6% (1296/1691)] thought it is very convenient to the immunization clinic, and 82.1% (1389/1691) rated their previous vaccination experience as good. Perceived convenience (χ2 = 85.77, p < .001) and satisfaction of vaccination (χ2 = 6.95, p = .031) showed a significant relationship with acceptability of non-NIP vaccines for their child (Table 2).

Table 2.

Association between categorical variables and acceptance of childhood non-NIP vaccines.

Variables	Total sample (N=1,691)	Willing(n=1,176)	Not willing(n=515)	χ2	p
Gender				10.70	<.001
Male	844 (49.9)	556 (47.3)	288 (55.9)
Female	847 (50.1)	620 (52.7)	227 (44.1)
Age (years)				189.74	<.001
20–29	600 (35.5)	530 (45.1)	70 (13.6)
30–39	974 (57.6)	549 (46.7)	425 (82.5)
≥40	117 (6.9)	97 (8.2)	20 (3.9)
Educational level				24.05	<.001
Junior high school or less	191 (11.3)	123 (10.5)	68 (13.2)
High school or technical school	633 (37.4)	420 (35.7)	213 (41.4)
College or above	867 (51.3)	633 (53.8)	234 (45.4)
Immigration status				16.66	<.001
Resident	859 (50.8)	636 (54.1)	223 (43.3)
Migrant	832 (49.2)	540 (45.9)	292 (56.7)
Monthly household income per capita (CNY)				19.75	<.001
<5000	112 (6.6)	62 (5.3)	50 (9.7)
5000–10,000	700 (41.4)	468 (39.8)	232 (45.0)
10,000–20,000	372 (22.0)	270 (23.0)	102 (19.8)
>20,000	507 (30.0)	376 (32.0)	131 (25.4)
Number of children at home				0.38	0.537
1	664 (59.82)	626 (59.7)	38 (61.29)
≥2	446 (40.18)	422 (40.3)	24 (38.71)
Convenience of immunization clinic				85.77	<.001
Convenient	1296 (76.6)	964 (82.0)	332 (64.5)
Moderate	258 (15.3)	160 (13.6)	98 (19.0)
Inconvenient	137 (8.1)	52 (4.4)	85 (16.5)
Satisfaction with vaccination				6.95	0.031
Good	1389 (82.1)	980 (83.3)	409 (79.4)
Moderate	244 (14.4)	164 (13.9)	80 (15.5)
Bad	58 (3.4)	32 (2.7)	26 (5.0)

Non-NIP vaccines knowledge and attitude

Of the 1,691 respondents, most (87.82%, 1,485) were aware that vaccines were divided into NIP and non-NIP vaccines, 1,479 (87.46%%, 1,479) were aware that non-NIP vaccines were voluntary vaccines, which were administered at their own cost, and 1,010 (91.0%) believed that non-NIP vaccines were helpful in the prevention of related diseases. A total of 868 (78.2%) participants agreed on the safety guaranteed by the non-NIP vaccines, and only 648 (58.4%) believed that fever or redness and pain at the vaccination site were usual adverse effects of vaccination. The respondents stated that the primary factors influencing their vaccine selection were safety (612, 55.1%) and effectiveness of vaccines (292, 26.3%). Further, 420 (37.8%) reported receiving information about the vaccines from the Internet and 418 (37.7%) from doctors. Several variables were correlated with the acceptability of childhood non-NIP vaccines in the bivariate analysis described in Table 3.

Table 3.

Bivariate correlates of childhood non-NIP vaccines acceptability for continuous variables.

	Mean(SD)
	Willing(n = 1,176)	Not wiling(n = 515)	p	Bivariate OR (95%CI)
Knowledge about non-NIP vaccinesa	3.5(0.9)	3.0(1.0)	<.001	1.73(1.62–1.86)
Perceived effectiveness of non-NIP vaccinesb	4.1(1.1)	3.6(1.1)	<.001	1.18(1.13–1.23)
Perceived safety of non-NIP vaccinesc	3.4(1.5)	2.9(1.7)	<.001	1.25(1.20–1.31)
Perceived necessity of non-NIP vaccinesd	3.6(1.3)	3.1(1.4)	<.001	1.33(1.27–1.40)
The price of non-NIP vaccines affects immunization decisione	3.1(1.5)	2.5(1.5)	<.001	1.34(1.27–1.42)

Note: OR =odds ratio; CI = confidence interval.

Note: aproportion of the 6 items pertaining to knowledge that were answered correctly (possible range = 0–1).

Note: b1item; 5-point response scale ranging from “not at all” to “very” (possible range = 1–5).

Note: c1item; 5-point response scale ranging from “not at all” to “very” (possible range = 1–5).

Note: d1item; 5-point response scale ranging from “not at all” to “very” (possible range = 1–5).

Note: e1item; 5-point response scale ranging from “very” to “not at all” (possible range = 1–5).

Factors associated with non-NIP vaccines acceptance

Through the multivariable analysis, it was found that the respondents were more willingly get non-NIP vaccines for their children in the following cases:

If they had an income of 10000–20000 CNY (OR = 1.65, 95%CI: 1.21–2.26) or more (OR = 2.23, 95%CI: 1.27–3.90)

An educational level of college or above (OR = 2.36, 95%CI:1.73-3.23)

Had a moderate (OR = 1.45, 95%CI: 1.01–2.11) or convenient (OR = 4.68, 95%CI: 2.91–7.52) of immunization

Had awareness about non-NIP vaccines (OR = 1.77, 95%CI: 1.51–2.07)

Perceived non-NIP vaccines as safe (OR = 1.20, 95%CI: 1.05–1.38)

Consider the lower effect of vaccine price on vaccination intention (OR = 1.43, 95%CI:1.27–1.62)

However, the respondents were less willing if they were in the 30–39 age group (OR = 0.25, 95%CI: 0.14–.45), and had moderate (OR = 0.55, 95%CI: 0.37–.82) or bad immunization experience (OR = 0.22, 95%CI:0.09–.51) (Table 4).

Table 4.

Multivariable correlates of non-NIP vaccine acceptability.

Variables	β	Wald	P	OR (95%CI)
Gender
Female				1
Male	−0.03	0.05	0.832	0.97 (.75–1.26)
Age (years)
20–29				ref
30–39	−1.37	21.73	<.001	0.25 (.14–.45)
≥40	−0.60	3.62	0.057	0.55 (.30–1.02)
Educational level
Junior high school or less				ref
High school or technical school	−0.40	2.65	0.104	0.67 (.42–1.08)
College or above	0.86	29.61	<.001	2.36 (1.73–3.23)
Immigration status
Migrant				ref
Resident	0.21	2.57	0.109	1.23 (.95–1.60)
Monthly household income per capita
≤5000				ref
5000–10,000	0.27	1.77	0.184	1.31 (.88–1.97)
10,000–0000	0.50	10.09	<.001	1.65 (1.21–2.26)
≥20,000	0.80	7.83	0.005	2.23 (1.27–3.90)
Convenience of immunization clinic
Inconvenient				ref
Moderate	0.38	3.94	0.047	1.45 (1.01–2.11)
Convenient	1.54	40.64	<.001	4.68 (2.91–7.52)
Immunization experience
Good				ref
Moderate	−0.59	8.53	0.003	0.55 (.37–.82)
Bad	−1.54	12.31	<0.001	0.22 (.09–.51)
Knowledge about non-NIP vaccines	0.57	51.30	<0.001	1.77 (1.51–2.07)
Perceived effectiveness of non-NIP vaccines	0.11	2.20	0.138	1.12 (.97–1.29)
Perceived safety of non-NIP vaccines	0.19	6.94	0.008	1.20 (1.05–1.38)
Perceived necessity of non-NIP vaccines	0.13	2.53	0.118	1.14 (.97–1.35)
The price of non-NIP vaccines affects immunization decisions	0.36	32.76	<.001	1.43 (1.27–1.62)

Discussion

Vaccination is considered to be one of the most remarkable public health interventions. The number of infectious diseases has been greatly reduced through vaccination,[13] and diseases, such as measles, rubella, and other respiratory diseases, have been effectively controlled. The COVID-19 pandemic might change people’s perception of vaccines. This study examined acceptability and hesitancy toward non-NIP vaccines among parents of children (0–6 years of age) and the factors associated with parents’ intention to vaccinate their children with non-NIP vaccines. Understanding these factors is significant for providing a scientific basis and theory for promoting the use of vaccines and strengthening the prevention and control of the infectious diseases.

We found that, in Shanghai, nearly 70% of parents would like to opt for non-NIP vaccines for their children at their own expense against COVID-19, and if non-NIP vaccines were covered by health insurance, the acceptability would increase to 86.3%. Considering China’s current budget, it is impossible to include all the non-NIP vaccines in NIP. To improve the coverage of non-NIP vaccines, a part of them can be included under residents’ health insurance. Previous research in other countries has also shown that incorporating vaccines into a publicly-funded program can significantly increase vaccination coverage,[14] and thus, it is necessary to explore the use of health insurance to pay for non-NIP vaccines in the future.

This study demonstrated that some demographic factors, such as age, educational level, immigration status, household income, were associated with parents’ vaccination intention. The multivariate analysis showed that the household income level was significantly correlated with the willingness to get non-NIP vaccines for children, and parents with a higher household income had higher acceptance of non-NIP vaccines for their children, which was consistent with other studies conducted in the provinces of the eastern, central and western part of China. The result showed that cost is an important barrier to the accessibility to self-paid vaccination in China.[15-17] Studies have shown a higher coverage rate of non-NIP vaccines associated with household income level and higher economic development.[18] Some non-NIP vaccines were expensive, therefore, family with lower income may be restricted the access to these self-paid vaccines. Immigration status influenced parents’ acceptability of non-NIP vaccines in this study. Immigration is thus another determinant of who is more likely to get their children vaccinated with non-NIP vaccines. Therefore, policymakers should communicate about vaccinations and health promotion among the immigrant population. In this study, parents with a college-level education or above were associated with greater acceptance of non-NIP vaccines. Studies have also shown is a positive correlation between the educational level and acceptability of non-NIP vaccines.[19-21] Parents’ education level may influence their knowledge, attitude and behavior, making them take advantage of vaccination services for their child.

Our analysis revealed that a greater price barrier perceived by parents was associated with lower acceptance of non-NIP vaccines for children. Economic income and price are important hindrance factors in the acceptance of non-NIP vaccines. Lack of confidence in the safety and knowledge of non-NIP vaccines directly lead to low acceptance, which is similar to previous studies on some non-NIP vaccines.[22]

Further, our study found that recognition of the safety, effectiveness, and necessity of non-NIP vaccines was associated with acceptance from parents. Parents were often decided whether their children should receive non-NIP vaccines. Therefore, their understanding and knowledge of non-NIP vaccines were significantly related to their acceptability.[23,24] We will expand publicity and education in the future. By publicizing non-NIP vaccines and generating awareness in community health service stations, community publicity boards, neighborhood committees, village committees and other places, the public’s vaccine awareness rate can be improved, further enhancing their willingness to vaccinate. Media channels can also be used as a further push to enhance the public’s knowledge of vaccination.

Studies have shown low public acceptance due to negative perceptions of the safety (19.2%) and effectiveness (42.9%) of the vaccines.[25] Contrastingly, in our study, the perceived safety and effectiveness of non-NIP vaccines were relatively high. It may be due to the following factors: first, the COVID-19 pandemic has changed people’s perception of vaccines across the country. Public acceptance of vaccines is at an unprecedented level, based on expectations for the novel coronavirus vaccine. This has greatly contributed to the promotion of immunization programs. Second, vaccination rates are high in economically developed areas where people’s health literacy is higher.

There were several limitations of this study. First, although our samples were from four different economically developing districts of Shanghai, the convenient sampling of parents who visited clinics to vaccinate their children during the proposed study period may not adequately represent Shanghai’s population. Second, the cross-sectional nature of this study limits the extent to which we can evaluate changes in the acceptance of vaccines over time. Third, the study design utilized face-to-face interviews. Thus, potential recall and social desirability bias could not be avoided, which could have affected our results.

In conclusion, nearly 70% of the surveyed parents were willing to get non-NIP vaccines for their children in the era of COVID-19. The acceptance would increase to 86.3% if non-NIP vaccines were covered by health insurance. Our results highlight that non-NIP vaccines acceptability may differ according to demographic characteristics, as well as the important role that convenience and satisfaction of vaccination play in acceptability of non-NIP vaccines. Furthermore, a lack of confidence in the safety and necessity and knowledge of non-NIP vaccines directly lead to low acceptance. These findings can guide the planning and development of future public health efforts to increase acceptability of non-NIP vaccines.